,date,title,url
0,2000-04-07,鲁抗医药年报,/disclosure/listedinfo/announcement/c/600789_1999_0.pdf
1,2000-08-08,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/600789_2000_1.pdf
2,2001-03-27,鲁抗医药年报,/disclosure/listedinfo/announcement/c/600789_2000_0.pdf
3,2001-06-19,鲁抗医药上市公司章程,/disclosure/listedinfo/announcement/c/600789_2001_g.pdf
4,2001-07-28,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/600789_2001_1.pdf
5,2002-03-19,鲁抗医药年报,/disclosure/listedinfo/announcement/c/600789_2001_n.pdf
6,2002-04-30,鲁抗医药第一季度季报,/disclosure/listedinfo/announcement/c/600789_2002_1.pdf
7,2002-06-29,鲁抗医药上市公司章程,/disclosure/listedinfo/announcement/c/600789_20020629_g.pdf
8,2002-06-29,鲁抗医药股东大会会议资料,/disclosure/listedinfo/announcement/c/600789_20020629_1.pdf
9,2002-06-29,鲁抗医药股东大会会议资料,/disclosure/listedinfo/announcement/c/600789_20020629_2.pdf
10,2002-08-13,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/2002-08-13/600789_2002_z.pdf
11,2002-10-22,鲁抗医药总经理工作细则,/disclosure/listedinfo/announcement/c/2002-10-22/600789_20021022_10.pdf
12,2002-10-22,鲁抗医药信息披露管理办法,/disclosure/listedinfo/announcement/c/2002-10-22/600789_20021022_8.pdf
13,2002-10-22,鲁抗医药薪酬与考核委员会实施细则,/disclosure/listedinfo/announcement/c/2002-10-22/600789_20021022_7.pdf
14,2002-10-22,鲁抗医药募集资金管理办法,/disclosure/listedinfo/announcement/c/2002-10-22/600789_20021022_4.pdf
15,2002-10-22,鲁抗医药监事会议事规则,/disclosure/listedinfo/announcement/c/2002-10-22/600789_20021022_3.pdf
16,2002-10-22,鲁抗医药关联交易管理办法,/disclosure/listedinfo/announcement/c/2002-10-22/600789_20021022_2.pdf
17,2002-10-22,鲁抗医药董事会战略委员会实施细则,/disclosure/listedinfo/announcement/c/2002-10-22/600789_20021022_9.pdf
18,2002-10-22,鲁抗医药董事会议事规则,/disclosure/listedinfo/announcement/c/2002-10-22/600789_20021022_1.pdf
19,2002-10-22,鲁抗医药董事会提名委员会实施细则,/disclosure/listedinfo/announcement/c/2002-10-22/600789_20021022_6.pdf
20,2002-10-22,鲁抗医药董事会审计委员会实施细则,/disclosure/listedinfo/announcement/c/2002-10-22/600789_20021022_5.pdf
21,2002-10-22,鲁抗医药第三季度季报,/disclosure/listedinfo/announcement/c/2002-10-22/600789_2002_3.pdf
22,2002-12-11,鲁抗医药招股意向书附录,/disclosure/listedinfo/announcement/c/2002-12-11/600789_20021211_3.pdf
23,2002-12-11,鲁抗医药招股意向书,/disclosure/listedinfo/announcement/c/2002-12-11/600789_20021211_1.pdf
24,2002-12-11,鲁抗医药发行公告,/disclosure/listedinfo/announcement/c/2002-12-11/600789_20021211_2.pdf
25,2003-03-03,鲁抗医药年报,/disclosure/listedinfo/announcement/c/2003-03-03/600789_2002_n.pdf
26,2003-04-11,鲁抗医药股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-04-11/600789_20030411_1.pdf
27,2003-04-19,鲁抗医药股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-04-19/600789_20030419_1.pdf
28,2003-04-22,鲁抗医药第一季度季报,/disclosure/listedinfo/announcement/c/2003-04-22/600789_2003_1.pdf
29,2003-04-23,鲁抗医药股东大会议事规则,/disclosure/listedinfo/announcement/c/2003-04-23/600789_20030423_1.pdf
30,2003-05-23,鲁抗医药增发招股说明书,/disclosure/listedinfo/announcement/c/2003-05-23/600789_20030523_1.pdf
31,2003-05-23,鲁抗医药发行公告,/disclosure/listedinfo/announcement/c/2003-05-23/600789_20030523_2.pdf
32,2003-06-06,鲁抗医药上市公告书,/disclosure/listedinfo/announcement/c/2003-06-06/600789_20030606_1.pdf
33,2003-07-24,鲁抗医药股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-07-24/600789_20030724_1.pdf
34,2003-08-01,鲁抗医药股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-08-01/600789_20030801_1.pdf
35,2003-08-02,鲁抗医药上市公司章程,/disclosure/listedinfo/announcement/c/2003-08-02/600789_20030802_g.pdf
36,2003-08-19,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/2003-08-19/600789_2003_z.pdf
37,2003-10-24,鲁抗医药第三季度季报,/disclosure/listedinfo/announcement/c/2003-10-24/600789_2003_3.pdf
38,2003-11-20,鲁抗医药股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-11-20/600789_20031120_1.pdf
39,2003-11-20,鲁抗医药股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-11-20/600789_20031120_2.pdf
40,2003-11-28,鲁抗医药投资者关系管理制度,/disclosure/listedinfo/announcement/c/2003-11-28/600789_20031128_1.pdf
41,2003-11-28,鲁抗医药股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-11-28/600789_20031128_2.pdf
42,2003-11-28,鲁抗医药股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-11-28/600789_20031128_3.pdf
43,2004-03-12,鲁抗医药年报（修订版）,/disclosure/listedinfo/announcement/c/2004-03-12/600789_2003_n.pdf
44,2004-03-12,鲁抗医药监事会决议公告,/disclosure/listedinfo/announcement/c/2004-03-12/600789_20040312_2.pdf
45,2004-03-12,鲁抗医药关于更换公司职工代表监事的公告,/disclosure/listedinfo/announcement/c/2004-03-12/600789_20040312_3.pdf
46,2004-03-12,鲁抗医药董事会决议公告暨召开2003年度股东大会通知,/disclosure/listedinfo/announcement/c/2004-03-12/600789_20040312_1.pdf
47,2004-04-10,鲁抗医药2003年度报告有关事项补充更正公告,/disclosure/listedinfo/announcement/c/2004-04-10/600789_20040410_1.pdf
48,2004-04-14,鲁抗医药关联交易公告,/disclosure/listedinfo/announcement/c/2004-04-14/600789_20040414_2.pdf
49,2004-04-14,鲁抗医药2003年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-04-14/600789_20040414_1.pdf
50,2004-04-16,鲁抗医药第一次回访报告,/disclosure/listedinfo/announcement/c/2004-04-16/600789_20040416_1.pdf
51,2004-04-23,鲁抗医药2003年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-04-23/600789_20040423_1.pdf
52,2004-04-23,鲁抗医药2003年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-04-23/600789_20040423_2.pdf
53,2004-04-24,鲁抗医药第一季度季报,/disclosure/listedinfo/announcement/c/2004-04-24/600789_2004_1.pdf
54,2004-06-08,鲁抗医药2003年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2004-06-08/600789_20040608_1.pdf
55,2004-06-23,鲁抗医药关于重大关联交易事项补充公告,/disclosure/listedinfo/announcement/c/2004-06-23/600789_20040623_2.pdf
56,2004-06-23,鲁抗医药关于对2003年工艺、设备技术引进费用会计核算的补充公告,/disclosure/listedinfo/announcement/c/2004-06-23/600789_20040623_3.pdf
57,2004-06-23,鲁抗医药董事会决议公告,/disclosure/listedinfo/announcement/c/2004-06-23/600789_20040623_1.pdf
58,2004-07-09,鲁抗医药关于收购控股股东部分资产实施情况的公告,/disclosure/listedinfo/announcement/c/2004-07-09/600789_20040709_1.pdf
59,2004-07-13,鲁抗医药2004年上半年业绩预警公告,/disclosure/listedinfo/announcement/c/2004-07-13/600789_20040713_1.pdf
60,2004-08-03,鲁抗医药关于会计师事务所对公司2003年会计差错调整专项审计的补充公告,/disclosure/listedinfo/announcement/c/2004-08-03/600789_20040803_1.pdf
61,2004-08-10,鲁抗医药澄清公告,/disclosure/listedinfo/announcement/c/2004-08-10/600789_20040810_1.pdf
62,2004-08-24,鲁抗医药半年报摘要,/disclosure/listedinfo/announcement/c/2004-08-24/600789_2004_zzy.pdf
63,2004-08-24,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/2004-08-24/600789_2004_z.pdf
64,2004-09-30,鲁抗医药关于2004年第三季度业绩预亏的提示性公告,/disclosure/listedinfo/announcement/c/2004-09-30/600789_20040930_1.pdf
65,2004-10-22,鲁抗医药第三季度季报,/disclosure/listedinfo/announcement/c/2004-10-22/600789_2004_3.pdf
66,2005-03-26,鲁抗医药年报摘要,/disclosure/listedinfo/announcement/c/2005-03-26/600789_2004_nzy.pdf
67,2005-03-26,鲁抗医药年报,/disclosure/listedinfo/announcement/c/2005-03-26/600789_2004_n.pdf
68,2005-03-26,鲁抗医药监事会决议公告,/disclosure/listedinfo/announcement/c/2005-03-26/600789_20050326_2.pdf
69,2005-03-26,鲁抗医药关于召开2004年年度股东大会的通知公告,/disclosure/listedinfo/announcement/c/2005-03-26/600789_20050326_3.pdf
70,2005-03-26,鲁抗医药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-03-26/600789_20050326_1.pdf
71,2005-04-13,鲁抗医药董事会关于修改公司2004年度股东大会议案的公告,/disclosure/listedinfo/announcement/c/2005-04-13/600789_20050413_1.pdf
72,2005-04-14,鲁抗医药2004年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-04-14/600789_20050414_1.pdf
73,2005-04-25,鲁抗医药第一季度季报,/disclosure/listedinfo/announcement/c/2005-04-25/600789_2005_1.pdf
74,2005-04-29,鲁抗医药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-29/600789_20050429_2.pdf
75,2005-04-29,鲁抗医药2004年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-04-29/600789_20050429_1.pdf
76,2005-08-20,鲁抗医药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-08-20/600789_20050820_1.pdf
77,2005-08-20,鲁抗医药半年报摘要,/disclosure/listedinfo/announcement/c/2005-08-20/600789_2005_zzy.pdf
78,2005-08-20,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/2005-08-20/600789_2005_z.pdf
79,2005-10-12,鲁抗医药关于2005年第三季度业绩预增的公告,/disclosure/listedinfo/announcement/c/2005-10-12/600789_20051012_1.pdf
80,2005-10-28,鲁抗医药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-10-28/600789_20051028_1.pdf
81,2005-10-28,鲁抗医药第三季度季报,/disclosure/listedinfo/announcement/c/2005-10-28/600789_2005_3.pdf
82,2005-12-20,鲁抗医药关于大股东所持股权依法冻结的公告,/disclosure/listedinfo/announcement/c/2005-12-20/600789_20051220_1.pdf
83,2006-04-04,鲁抗医药年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2006-04-04/600789_2005_nzy.pdf
84,2006-04-04,鲁抗医药年报（修订版）,/disclosure/listedinfo/announcement/c/2006-04-04/600789_2005_n.pdf
85,2006-04-04,鲁抗医药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-04/600789_20060404_2.pdf
86,2006-04-04,鲁抗医药关于召开公司2005年年度股东大会通知的公告,/disclosure/listedinfo/announcement/c/2006-04-04/600789_20060404_3.pdf
87,2006-04-04,鲁抗医药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-04/600789_20060404_1.pdf
88,2006-04-04,鲁抗医药2005年度与关联方资金往来及对外担保情况的专项审计报告（修订版）,/disclosure/listedinfo/announcement/c/2006-04-04/600789_20060404_4.pdf
89,2006-04-08,鲁抗医药2005年年度报告摘要补充的公告,/disclosure/listedinfo/announcement/c/2006-04-08/600789_20060408_1.pdf
90,2006-04-24,鲁抗医药监事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2006-04-24/600789_20060424_2.pdf
91,2006-04-24,鲁抗医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2006-04-24/600789_20060424_1.pdf
92,2006-04-24,鲁抗医药第一季度季报（修订版）,/disclosure/listedinfo/announcement/c/2006-04-24/600789_2006_1.pdf
93,2006-05-09,鲁抗医药2005年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-05-09/600789_20060509_1.pdf
94,2006-05-13,鲁抗医药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-05-13/600789_20060513_3.pdf
95,2006-05-13,鲁抗医药公司章程（2006修订）,/disclosure/listedinfo/announcement/c/2006-05-13/600789_20060513_g.pdf
96,2006-05-13,鲁抗医药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-05-13/600789_20060513_2.pdf
97,2006-05-13,鲁抗医药2005年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-05-13/600789_20060513_1.pdf
98,2006-05-13,鲁抗医药2005年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-05-13/600789_20060513_4.pdf
99,2006-05-20,鲁抗医药关于大股东所持股权依法轮候冻结的公告,/disclosure/listedinfo/announcement/c/2006-05-20/600789_20060520_1.pdf
100,2006-05-27,鲁抗医药关于2005年年度报告及2006 年第一季度报告的更正公告,/disclosure/listedinfo/announcement/c/2006-05-27/600789_20060527_1.pdf
101,2006-06-03,鲁抗医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2006-06-03/600789_20060603_1.pdf
102,2006-07-03,鲁抗医药关于股权分置改革进展情况的公告,/disclosure/listedinfo/announcement/c/2006-07-03/600789_20060703_1.pdf
103,2006-07-31,鲁抗医药关于股权分置改革提示性公告,/disclosure/listedinfo/announcement/c/2006-07-31/600789_20060731_1.pdf
104,2006-08-04,鲁抗医药关于取消股权分置改革的公告,/disclosure/listedinfo/announcement/c/2006-08-04/600789_20060804_1.pdf
105,2006-08-31,鲁抗医药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-08-31/600789_20060831_2.pdf
106,2006-08-31,鲁抗医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2006-08-31/600789_20060831_1.pdf
107,2006-08-31,鲁抗医药半年报摘要,/disclosure/listedinfo/announcement/c/2006-08-31/600789_2006_zzy.pdf
108,2006-08-31,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/2006-08-31/600789_2006_z.pdf
109,2006-09-11,鲁抗医药关于股权分置改革的提示性公告,/disclosure/listedinfo/announcement/c/2006-09-11/600789_20060911_1.pdf
110,2006-09-12,鲁抗医药股权分置改革之保荐意见书,/disclosure/listedinfo/announcement/c/2006-09-12/600789_20060912_4.pdf
111,2006-09-12,鲁抗医药股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2006-09-12/600789_20060912_3.pdf
112,2006-09-12,鲁抗医药股权分置改革说明书,/disclosure/listedinfo/announcement/c/2006-09-12/600789_20060912_2.pdf
113,2006-09-12,鲁抗医药股权分置改革的法律意见书,/disclosure/listedinfo/announcement/c/2006-09-12/600789_20060912_5.pdf
114,2006-09-12,鲁抗医药独立董事关于股权分置改革之独立意见,/disclosure/listedinfo/announcement/c/2006-09-12/600789_20060912_6.pdf
115,2006-09-12,鲁抗医药董事会临时会议决议公告以及关于召开2006年第一次临时股东大会暨相关股东会议的通知,/disclosure/listedinfo/announcement/c/2006-09-12/600789_20060912_1.pdf
116,2006-09-12,鲁抗医药董事会关于2006年第一次临时股东大会暨相关股东会议的投票委托征集函,/disclosure/listedinfo/announcement/c/2006-09-12/600789_20060912_7.pdf
117,2006-09-21,鲁抗医药关于股权分置改革方案沟通协商情况暨修改股权分置改革方案的公告,/disclosure/listedinfo/announcement/c/2006-09-21/600789_20060921_1.pdf
118,2006-09-21,鲁抗医药股权分置改革之补充保荐意见书,/disclosure/listedinfo/announcement/c/2006-09-21/600789_20060921_4.pdf
119,2006-09-21,鲁抗医药股权分置改革说明书摘要（修订稿）,/disclosure/listedinfo/announcement/c/2006-09-21/600789_20060921_3.pdf
120,2006-09-21,鲁抗医药股权分置改革说明书（修订稿）,/disclosure/listedinfo/announcement/c/2006-09-21/600789_20060921_2.pdf
121,2006-09-21,鲁抗医药股权分置改革的补充法律意见书,/disclosure/listedinfo/announcement/c/2006-09-21/600789_20060921_5.pdf
122,2006-09-21,鲁抗医药独立董事关于股权分置改革之补充独立意见,/disclosure/listedinfo/announcement/c/2006-09-21/600789_20060921_6.pdf
123,2006-09-27,鲁抗医药关于召开2006年第一次临时股东大会暨相关股东会议的第一次提示性公告,/disclosure/listedinfo/announcement/c/2006-09-27/600789_20060927_1.pdf
124,2006-09-28,鲁抗医药国家股持股单位的提示性公告,/disclosure/listedinfo/announcement/c/2006-09-28/600789_20060928_1.pdf
125,2006-10-11,S鲁抗药关于召开2006年第一次临时股东大会暨相关股东会议的第二次提示性公告,/disclosure/listedinfo/announcement/c/2006-10-11/600789_20061011_1.pdf
126,2006-10-11,S鲁抗药关于股改方案获国资部门批复的公告,/disclosure/listedinfo/announcement/c/2006-10-11/600789_20061011_2.pdf
127,2006-10-17,S鲁抗药2006年第一次临时股东大会暨相关股东会议的法律意见书,/disclosure/listedinfo/announcement/c/2006-10-17/600789_20061017_2.pdf
128,2006-10-17,S鲁抗药2006年第一次临时股东大会暨相关股东会议表决结果的公告,/disclosure/listedinfo/announcement/c/2006-10-17/600789_20061017_1.pdf
129,2006-10-26,S鲁抗药股权分置改革方案实施公告,/disclosure/listedinfo/announcement/c/2006-10-26/600789_20061026_1.pdf
130,2006-10-31,鲁抗医药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-10-31/600789_20061031_2.pdf
131,2006-10-31,鲁抗医药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-10-31/600789_20061031_1.pdf
132,2006-10-31,鲁抗医药第三季度季报,/disclosure/listedinfo/announcement/c/2006-10-31/600789_2006_3.pdf
133,2006-11-04,鲁抗医药国家股管理权变更的公告,/disclosure/listedinfo/announcement/c/2006-11-04/600789_20061104_1.pdf
134,2006-12-27,鲁抗医药关于大股东所持股权依法继续冻结的公告,/disclosure/listedinfo/announcement/c/2006-12-27/600789_20061227_1.pdf
135,2006-12-30,鲁抗医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2006-12-30/600789_20061230_1.pdf
136,2007-01-31,鲁抗医药2006年度业绩预亏公告,/disclosure/listedinfo/announcement/c/2007-01-31/600789_20070131_1.pdf
137,2007-03-23,鲁抗医药关于部分股权解除轮候冻结的公告,/disclosure/listedinfo/announcement/c/2007-03-23/600789_20070323_1.pdf
138,2007-04-28,鲁抗医药年报摘要,/disclosure/listedinfo/announcement/c/2007-04-28/600789_2006_nzy.pdf
139,2007-04-28,鲁抗医药年报,/disclosure/listedinfo/announcement/c/2007-04-28/600789_2006_n.pdf
140,2007-04-28,鲁抗医药监事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-28/600789_20070428_2.pdf
141,2007-04-28,鲁抗医药关于召开公司2006年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2007-04-28/600789_20070428_3.pdf
142,2007-04-28,鲁抗医药关于收购鲁抗集团公司三家控股子公司股权的关联交易公告,/disclosure/listedinfo/announcement/c/2007-04-28/600789_20070428_4.pdf
143,2007-04-28,鲁抗医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-28/600789_20070428_1.pdf
144,2007-04-28,鲁抗医药第一季度季报,/disclosure/listedinfo/announcement/c/2007-04-28/600789_2007_1.pdf
145,2007-04-28,鲁抗医药2006年度与关联方资金往来的专项审计报告,/disclosure/listedinfo/announcement/c/2007-04-28/600789_20070428_5.pdf
146,2007-05-17,鲁抗医药2006年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-05-17/600789_20070517_1.pdf
147,2007-05-26,鲁抗医药监事会议事规则（2007修订）,/disclosure/listedinfo/announcement/c/2007-05-26/600789_20070526_5.pdf
148,2007-05-26,鲁抗医药股东大会议事规则（2007修订）,/disclosure/listedinfo/announcement/c/2007-05-26/600789_20070526_3.pdf
149,2007-05-26,鲁抗医药公司章程（2007修订）,/disclosure/listedinfo/announcement/c/2007-05-26/600789_20070526_g.pdf
150,2007-05-26,鲁抗医药董事会议事规则（2007修订）,/disclosure/listedinfo/announcement/c/2007-05-26/600789_20070526_4.pdf
151,2007-05-26,鲁抗医药2006年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-05-26/600789_20070526_1.pdf
152,2007-05-26,鲁抗医药2006年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-05-26/600789_20070526_2.pdf
153,2007-06-02,鲁抗医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2007-06-02/600789_20070602_1.pdf
154,2007-06-14,鲁抗医药关于国家股股权依法继续冻结的公告,/disclosure/listedinfo/announcement/c/2007-06-14/600789_20070614_1.pdf
155,2007-06-29,鲁抗医药信息披露管理制度,/disclosure/listedinfo/announcement/c/2007-06-29/600789_20070629_2.pdf
156,2007-06-29,鲁抗医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-06-29/600789_20070629_1.pdf
157,2007-08-09,鲁抗医药监事会决议公告,/disclosure/listedinfo/announcement/c/2007-08-09/600789_20070809_2.pdf
158,2007-08-09,鲁抗医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-08-09/600789_20070809_1.pdf
159,2007-08-09,鲁抗医药半年报摘要,/disclosure/listedinfo/announcement/c/2007-08-09/600789_2007_zzy.pdf
160,2007-08-09,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/2007-08-09/600789_2007_z.pdf
161,2007-08-09,鲁抗医药2007年公司治理自查报告和整改计划,/disclosure/listedinfo/announcement/c/2007-08-09/600789_20070809_3.pdf
162,2007-09-22,鲁抗医药关于公司治理专项活动公众评议方式的公告,/disclosure/listedinfo/announcement/c/2007-09-22/600789_20070922_1.pdf
163,2007-10-29,鲁抗医药投资者关系管理制度,/disclosure/listedinfo/announcement/c/2007-10-29/600789_20071029_6.pdf
164,2007-10-29,鲁抗医药监事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-10-29/600789_20071029_2.pdf
165,2007-10-29,鲁抗医药对外投资管理制度,/disclosure/listedinfo/announcement/c/2007-10-29/600789_20071029_3.pdf
166,2007-10-29,鲁抗医药董事会战略委员会实施细则,/disclosure/listedinfo/announcement/c/2007-10-29/600789_20071029_4.pdf
167,2007-10-29,鲁抗医药董事会薪酬与考核委员会工作细则,/disclosure/listedinfo/announcement/c/2007-10-29/600789_20071029_5.pdf
168,2007-10-29,鲁抗医药董事会提名委员会工作细则,/disclosure/listedinfo/announcement/c/2007-10-29/600789_20071029_7.pdf
169,2007-10-29,鲁抗医药董事会审计委员会工作细则,/disclosure/listedinfo/announcement/c/2007-10-29/600789_20071029_8.pdf
170,2007-10-29,鲁抗医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-10-29/600789_20071029_1.pdf
171,2007-10-29,鲁抗医药第三季度季报,/disclosure/listedinfo/announcement/c/2007-10-29/600789_2007_3.pdf
172,2007-10-31,鲁抗医药关于公司治理专项活动的整改报告,/disclosure/listedinfo/announcement/c/2007-10-31/600789_20071031_2.pdf
173,2007-10-31,鲁抗医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-10-31/600789_20071031_1.pdf
174,2007-11-03,鲁抗医药第三季度季报（修订版）,/disclosure/listedinfo/announcement/c/2007-11-03/600789_2007_3.pdf
175,2007-11-03,鲁抗医药2007年第三季度报告更正公告,/disclosure/listedinfo/announcement/c/2007-11-03/600789_20071103_1.pdf
176,2007-12-13,鲁抗医药关于国家股股权解除冻结的公告,/disclosure/listedinfo/announcement/c/2007-12-13/600789_20071213_1.pdf
177,2007-12-29,鲁抗医药总经理工作细则,/disclosure/listedinfo/announcement/c/2007-12-29/600789_20071229_2.pdf
178,2007-12-29,鲁抗医药关联交易管理制度,/disclosure/listedinfo/announcement/c/2007-12-29/600789_20071229_3.pdf
179,2007-12-29,鲁抗医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-12-29/600789_20071229_1.pdf
180,2008-01-04,鲁抗医药关于明确公司国家股持股单位的公告,/disclosure/listedinfo/announcement/c/2008-01-04/600789_20080104_1.pdf
181,2008-01-17,鲁抗医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2008-01-17/600789_20080117_1.pdf
182,2008-01-29,鲁抗医药2007年1-12月业绩预告,/disclosure/listedinfo/announcement/c/2008-01-29/600789_20080129_1.pdf
183,2008-02-19,鲁抗医药关于为山东工程机械集团有限公司提供相互担保的公告,/disclosure/listedinfo/announcement/c/2008-02-19/600789_20080219_2.pdf
184,2008-02-19,鲁抗医药关于为参股子公司提供担保的公告,/disclosure/listedinfo/announcement/c/2008-02-19/600789_20080219_3.pdf
185,2008-02-19,鲁抗医药关于收购山东民生煤化有限公司医药资产（菏泽公司股权）的公告,/disclosure/listedinfo/announcement/c/2008-02-19/600789_20080219_4.pdf
186,2008-02-19,鲁抗医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-02-19/600789_20080219_1.pdf
187,2008-03-29,鲁抗医药审计委员会工作规程,/disclosure/listedinfo/announcement/c/2008-03-29/600789_20080329_6.pdf
188,2008-03-29,鲁抗医药年报摘要,/disclosure/listedinfo/announcement/c/2008-03-29/600789_2007_nzy.pdf
189,2008-03-29,鲁抗医药年报,/disclosure/listedinfo/announcement/c/2008-03-29/600789_2007_n.pdf
190,2008-03-29,鲁抗医药监事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-29/600789_20080329_2.pdf
191,2008-03-29,鲁抗医药关于召开2007年度股东大会通知的公告,/disclosure/listedinfo/announcement/c/2008-03-29/600789_20080329_3.pdf
192,2008-03-29,鲁抗医药独立董事年报工作制度,/disclosure/listedinfo/announcement/c/2008-03-29/600789_20080329_5.pdf
193,2008-03-29,鲁抗医药董事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-29/600789_20080329_1.pdf
194,2008-03-29,鲁抗医药2007年度与关联方资金往来的专项审计报告,/disclosure/listedinfo/announcement/c/2008-03-29/600789_20080329_4.pdf
195,2008-04-26,鲁抗医药第一季度季报,/disclosure/listedinfo/announcement/c/2008-04-26/600789_2008_1.pdf
196,2008-05-14,鲁抗医药2007年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-05-14/600789_20080514_1.pdf
197,2008-05-23,鲁抗医药监事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-05-23/600789_20080523_2.pdf
198,2008-05-23,鲁抗医药2007年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-05-23/600789_20080523_1.pdf
199,2008-05-23,鲁抗医药2007年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-05-23/600789_20080523_3.pdf
200,2008-05-24,鲁抗医药董事会临时会议决议及召开临时股东大会通知的公告,/disclosure/listedinfo/announcement/c/2008-05-24/600789_20080524_1.pdf
201,2008-06-03,鲁抗医药2008年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-06-03/600789_20080603_1.pdf
202,2008-06-07,鲁抗医药关于向四川地震灾区人民捐赠的公告,/disclosure/listedinfo/announcement/c/2008-06-07/600789_20080607_1.pdf
203,2008-06-11,鲁抗医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-06-11/600789_20080611_2.pdf
204,2008-06-11,鲁抗医药2008年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-06-11/600789_20080611_1.pdf
205,2008-06-11,鲁抗医药2008年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-06-11/600789_20080611_3.pdf
206,2008-07-01,鲁抗医药关于收购鲁抗集团公司三家子公司股权进展情况的公告,/disclosure/listedinfo/announcement/c/2008-07-01/600789_20080701_1.pdf
207,2008-07-05,鲁抗医药关于收购山东民生煤化有限公司医药资产（菏泽公司股权）情况的公告,/disclosure/listedinfo/announcement/c/2008-07-05/600789_20080705_1.pdf
208,2008-07-10,鲁抗医药2008年上半年业绩预增公告,/disclosure/listedinfo/announcement/c/2008-07-10/600789_20080710_1.pdf
209,2008-07-19,鲁抗医药关于公司治理整改报告所列事项整改情况的说明,/disclosure/listedinfo/announcement/c/2008-07-19/600789_20080719_2.pdf
210,2008-07-19,鲁抗医药防止控股股东及关联方占用公司资金行为的管理规定,/disclosure/listedinfo/announcement/c/2008-07-19/600789_20080719_3.pdf
211,2008-07-19,鲁抗医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-07-19/600789_20080719_1.pdf
212,2008-08-29,鲁抗医药半年报摘要,/disclosure/listedinfo/announcement/c/2008-08-29/600789_2008_zzy.pdf
213,2008-08-29,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/2008-08-29/600789_2008_z.pdf
214,2008-10-21,鲁抗医药更正公告,/disclosure/listedinfo/announcement/c/2008-10-21/600789_20081021_1.pdf
215,2008-10-31,鲁抗医药资产减值准备计提和资产核销管理制度,/disclosure/listedinfo/announcement/c/2008-10-31/600789_20081031_3.pdf
216,2008-10-31,鲁抗医药五届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2008-10-31/600789_20081031_2.pdf
217,2008-10-31,鲁抗医药五届董事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2008-10-31/600789_20081031_1.pdf
218,2008-10-31,鲁抗医药第三季度季报,/disclosure/listedinfo/announcement/c/2008-10-31/600789_2008_3.pdf
219,2008-11-29,鲁抗医药关于收购山东鲁抗舍里乐药业有限公司股权进展情况的公告,/disclosure/listedinfo/announcement/c/2008-11-29/600789_20081129_1.pdf
220,2009-02-28,鲁抗医药五届董事会第二十一次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2009-02-28/600789_20090228_1.pdf
221,2009-03-27,鲁抗医药五届监事会十二次会议决议公告,/disclosure/listedinfo/announcement/c/2009-03-27/600789_20090327_2.pdf
222,2009-03-27,鲁抗医药五届董事会二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2009-03-27/600789_20090327_1.pdf
223,2009-03-27,鲁抗医药年报摘要,/disclosure/listedinfo/announcement/c/2009-03-27/600789_2008_nzy.pdf
224,2009-03-27,鲁抗医药年报,/disclosure/listedinfo/announcement/c/2009-03-27/600789_2008_n.pdf
225,2009-03-27,鲁抗医药关于召开公司2008年年度股东大会通知的公告,/disclosure/listedinfo/announcement/c/2009-03-27/600789_20090327_3.pdf
226,2009-03-27,鲁抗医药2008年度与关联方资金往来的专项审计报告,/disclosure/listedinfo/announcement/c/2009-03-27/600789_20090327_4.pdf
227,2009-04-15,鲁抗医药2008年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-04-15/600789_20090415_1.pdf
228,2009-04-24,鲁抗医药六届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2009-04-24/600789_20090424_3.pdf
229,2009-04-24,鲁抗医药六届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2009-04-24/600789_20090424_2.pdf
230,2009-04-24,鲁抗医药公司章程（2009修订）,/disclosure/listedinfo/announcement/c/2009-04-24/600789_20090424_g.pdf
231,2009-04-24,鲁抗医药2008年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-04-24/600789_20090424_1.pdf
232,2009-04-24,鲁抗医药2008年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-04-24/600789_20090424_4.pdf
233,2009-04-29,鲁抗医药第一季度季报,/disclosure/listedinfo/announcement/c/2009-04-29/600789_2009_1.pdf
234,2009-06-27,鲁抗医药关于第二大股东股改转增股份处置有关事宜的公告,/disclosure/listedinfo/announcement/c/2009-06-27/600789_20090627_1.pdf
235,2009-08-01,鲁抗医药关于第二大股东股改转增股份处置进展情况的公告,/disclosure/listedinfo/announcement/c/2009-08-01/600789_20090801_1.pdf
236,2009-08-24,鲁抗医药六届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2009-08-24/600789_20090824_2.pdf
237,2009-08-24,鲁抗医药六届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2009-08-24/600789_20090824_1.pdf
238,2009-08-24,鲁抗医药半年报摘要,/disclosure/listedinfo/announcement/c/2009-08-24/600789_2009_zzy.pdf
239,2009-08-24,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/2009-08-24/600789_2009_z.pdf
240,2009-08-29,鲁抗医药关于公司及下属子公司产品进入《国家基本药物目录》的提示性公告,/disclosure/listedinfo/announcement/c/2009-08-29/600789_20090829_1.pdf
241,2009-09-02,鲁抗医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2009-09-02/600789_20090902_1.pdf
242,2009-09-25,鲁抗医药股改限售流通股上市公告,/disclosure/listedinfo/announcement/c/2009-09-25/600789_20090925_1.pdf
243,2009-10-26,鲁抗医药第三季度季报,/disclosure/listedinfo/announcement/c/2009-10-26/600789_2009_3.pdf
244,2009-11-24,鲁抗医药关于通过国家高新技术企业认定的公告,/disclosure/listedinfo/announcement/c/2009-11-24/600789_20091124_1.pdf
245,2009-12-05,鲁抗医药关于董事辞职的公告,/disclosure/listedinfo/announcement/c/2009-12-05/600789_20091205_1.pdf
246,2010-03-27,鲁抗医药日常关联交易公告,/disclosure/listedinfo/announcement/c/2010-03-27/600789_20100327_4.pdf
247,2010-03-27,鲁抗医药年报摘要,/disclosure/listedinfo/announcement/c/2010-03-27/600789_2009_nzy.pdf
248,2010-03-27,鲁抗医药年报,/disclosure/listedinfo/announcement/c/2010-03-27/600789_2009_n.pdf
249,2010-03-27,鲁抗医药内部控制制度,/disclosure/listedinfo/announcement/c/2010-03-27/600789_20100327_6.pdf
250,2010-03-27,鲁抗医药六届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-27/600789_20100327_2.pdf
251,2010-03-27,鲁抗医药六届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-27/600789_20100327_1.pdf
252,2010-03-27,鲁抗医药关于召开公司2009年度股东大会通知的公告,/disclosure/listedinfo/announcement/c/2010-03-27/600789_20100327_3.pdf
253,2010-03-27,鲁抗医药2009年度与关联方资金往来的专项审计报告,/disclosure/listedinfo/announcement/c/2010-03-27/600789_20100327_5.pdf
254,2010-04-09,鲁抗医药2010年第一季度业绩预增公告,/disclosure/listedinfo/announcement/c/2010-04-09/600789_20100409_1.pdf
255,2010-04-21,鲁抗医药内幕信息知情人登记制度,/disclosure/listedinfo/announcement/c/2010-04-21/600789_20100421_3.pdf
256,2010-04-21,鲁抗医药六届监事会第六次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-21/600789_20100421_2.pdf
257,2010-04-21,鲁抗医药六届董事会第六次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-21/600789_20100421_1.pdf
258,2010-04-21,鲁抗医药第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-21/600789_2010_1.pdf
259,2010-05-18,鲁抗医药2009年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-05-18/600789_20100518_1.pdf
260,2010-05-27,鲁抗医药2009年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-05-27/600789_20100527_1.pdf
261,2010-05-27,鲁抗医药2009年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-05-27/600789_20100527_2.pdf
262,2010-05-29,鲁抗医药关于两子公司合并完成的公告,/disclosure/listedinfo/announcement/c/2010-05-29/600789_20100529_1.pdf
263,2010-06-22,鲁抗医药与邹城市人民政府签署战略合作框架协议的公告,/disclosure/listedinfo/announcement/c/2010-06-22/600789_20100622_1.pdf
264,2010-07-09,鲁抗医药2010年上半年业绩预增公告,/disclosure/listedinfo/announcement/c/2010-07-09/600789_20100709_1.pdf
265,2010-07-28,鲁抗医药关于更换保荐代表人的公告,/disclosure/listedinfo/announcement/c/2010-07-28/600789_20100728_1.pdf
266,2010-08-26,鲁抗医药六届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2010-08-26/600789_20100826_2.pdf
267,2010-08-26,鲁抗医药第六届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2010-08-26/600789_20100826_1.pdf
268,2010-08-26,鲁抗医药半年报摘要,/disclosure/listedinfo/announcement/c/2010-08-26/600789_2010_zzy.pdf
269,2010-08-26,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/2010-08-26/600789_2010_z.pdf
270,2010-09-13,鲁抗医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2010-09-13/600789_20100913_1.pdf
271,2010-10-27,鲁抗医药关于董事辞职的公告,/disclosure/listedinfo/announcement/c/2010-10-27/600789_20101027_1.pdf
272,2010-10-29,鲁抗医药第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-29/600789_2010_3.pdf
273,2011-02-26,鲁抗医药2010年度业绩预告修正公告,/disclosure/listedinfo/announcement/c/2011-02-26/600789_20110226_1.pdf
274,2011-03-12,鲁抗医药日常关联交易公告,/disclosure/listedinfo/announcement/c/2011-03-12/600789_20110312_4.pdf
275,2011-03-12,鲁抗医药年报摘要,/disclosure/listedinfo/announcement/c/2011-03-12/600789_2010_nzy.pdf
276,2011-03-12,鲁抗医药年报,/disclosure/listedinfo/announcement/c/2011-03-12/600789_2010_n.pdf
277,2011-03-12,鲁抗医药六届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2011-03-12/600789_20110312_2.pdf
278,2011-03-12,鲁抗医药六届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2011-03-12/600789_20110312_1.pdf
279,2011-03-12,鲁抗医药关于召开公司2010年度股东大会通知的公告,/disclosure/listedinfo/announcement/c/2011-03-12/600789_20110312_3.pdf
280,2011-03-12,鲁抗医药2010年度与关联方资金往来的专项审计报告,/disclosure/listedinfo/announcement/c/2011-03-12/600789_20110312_5.pdf
281,2011-03-25,鲁抗医药关于子公司明治鲁抗医药有限公司股权转让完成的公告,/disclosure/listedinfo/announcement/c/2011-03-25/600789_20110325_1.pdf
282,2011-04-27,鲁抗医药六届监事会第十次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-27/600789_20110427_2.pdf
283,2011-04-27,鲁抗医药六届董事会第十次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-27/600789_20110427_1.pdf
284,2011-04-27,鲁抗医药董事会秘书工作细则,/disclosure/listedinfo/announcement/c/2011-04-27/600789_20110427_3.pdf
285,2011-04-27,鲁抗医药第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-27/600789_2011_1.pdf
286,2011-05-18,鲁抗医药2010年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-05-18/600789_20110518_1.pdf
287,2011-05-27,鲁抗医药2010年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-05-27/600789_20110527_1.pdf
288,2011-05-27,鲁抗医药2010年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-05-27/600789_20110527_2.pdf
289,2011-08-26,鲁抗医药六届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2011-08-26/600789_20110826_2.pdf
290,2011-08-26,鲁抗医药六届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2011-08-26/600789_20110826_1.pdf
291,2011-08-26,鲁抗医药关于为子公司山东鲁抗舍里乐药业有限公司提供银行贷款担保的公告,/disclosure/listedinfo/announcement/c/2011-08-26/600789_20110826_3.pdf
292,2011-08-26,鲁抗医药半年报摘要,/disclosure/listedinfo/announcement/c/2011-08-26/600789_2011_zzy.pdf
293,2011-08-26,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/2011-08-26/600789_2011_z.pdf
294,2011-10-31,鲁抗医药第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-31/600789_2011_3.pdf
295,2011-11-08,鲁抗医药第三季度季报（修订版）,/disclosure/listedinfo/announcement/c/2011-11-08/600789_2011_3.pdf
296,2011-11-08,鲁抗医药第三季度报告补充公告,/disclosure/listedinfo/announcement/c/2011-11-08/600789_20111108_1.pdf
297,2011-11-22,鲁抗医药关于公司技术中心被认定为国家级企业技术中心的公告,/disclosure/listedinfo/announcement/c/2011-11-22/600789_20111122_1.pdf
298,2011-12-17,鲁抗医药股改限售流通股上市公告,/disclosure/listedinfo/announcement/c/2011-12-17/600789_20111217_1.pdf
299,2011-12-21,鲁抗医药六届监事会第十三次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2011-12-21/600789_20111221_2.pdf
300,2011-12-21,鲁抗医药六届董事会第十三次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2011-12-21/600789_20111221_1.pdf
301,2011-12-21,鲁抗医药股权收购公告,/disclosure/listedinfo/announcement/c/2011-12-21/600789_20111221_3.pdf
302,2012-01-06,鲁抗医药六届董事会第十四次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2012-01-06/600789_20120106_1.pdf
303,2012-01-06,鲁抗医药关于关联方提供财务资助并终止本公司中期票据发行的公告,/disclosure/listedinfo/announcement/c/2012-01-06/600789_20120106_2.pdf
304,2012-01-20,鲁抗医药2011年度业绩预减公告,/disclosure/listedinfo/announcement/c/2012-01-20/600789_20120120_1.pdf
305,2012-03-14,鲁抗医药关于青海大地药业有限公司股权收购完成的公告,/disclosure/listedinfo/announcement/c/2012-03-14/600789_20120314_1.pdf
306,2012-04-16,鲁抗医药日常关联交易公告,/disclosure/listedinfo/announcement/c/2012-04-16/600789_20120416_4.pdf
307,2012-04-16,鲁抗医药年报摘要,/disclosure/listedinfo/announcement/c/2012-04-16/600789_2011_nzy.pdf
308,2012-04-16,鲁抗医药年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2012-04-16/600789_20120416_8.pdf
309,2012-04-16,鲁抗医药年报,/disclosure/listedinfo/announcement/c/2012-04-16/600789_2011_n.pdf
310,2012-04-16,鲁抗医药内部控制规范实施工作的方案,/disclosure/listedinfo/announcement/c/2012-04-16/600789_20120416_7.pdf
311,2012-04-16,鲁抗医药六届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2012-04-16/600789_20120416_2.pdf
312,2012-04-16,鲁抗医药六届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2012-04-16/600789_20120416_1.pdf
313,2012-04-16,鲁抗医药关于召开公司2011年度股东大会通知的公告,/disclosure/listedinfo/announcement/c/2012-04-16/600789_20120416_3.pdf
314,2012-04-16,鲁抗医药2011年度与关联方资金往来的专项审计报告,/disclosure/listedinfo/announcement/c/2012-04-16/600789_20120416_5.pdf
315,2012-04-16,鲁抗医药2011年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2012-04-16/600789_20120416_6.pdf
316,2012-04-28,鲁抗医药第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-28/600789_2012_1.pdf
317,2012-05-05,鲁抗医药2011年度股东大会会议材料,/disclosure/listedinfo/announcement/c/2012-05-05/600789_20120505_1.pdf
318,2012-05-17,鲁抗医药七届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2012-05-17/600789_20120517_3.pdf
319,2012-05-17,鲁抗医药七届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2012-05-17/600789_20120517_2.pdf
320,2012-05-17,鲁抗医药2011年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-05-17/600789_20120517_1.pdf
321,2012-05-17,鲁抗医药2011年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-05-17/600789_20120517_4.pdf
322,2012-05-30,鲁抗医药关于本公司及所属子公司胶囊剂产品铬超标有关情况的公告,/disclosure/listedinfo/announcement/c/2012-05-30/600789_20120530_1.pdf
323,2012-07-09,鲁抗医药2011年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2012-07-09/600789_20120709_1.pdf
324,2012-08-31,鲁抗医药七届监事会第二会议决议公告,/disclosure/listedinfo/announcement/c/2012-08-31/600789_20120831_2.pdf
325,2012-08-31,鲁抗医药七届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2012-08-31/600789_20120831_1.pdf
326,2012-08-31,鲁抗医药关于增加公司2012年度日常关联交易额度的公告,/disclosure/listedinfo/announcement/c/2012-08-31/600789_20120831_4.pdf
327,2012-08-31,鲁抗医药关于收购全资孙公司山东鲁抗动植物药品经营有限公司股权的公告,/disclosure/listedinfo/announcement/c/2012-08-31/600789_20120831_3.pdf
328,2012-08-31,鲁抗医药半年报摘要,/disclosure/listedinfo/announcement/c/2012-08-31/600789_2012_zzy.pdf
329,2012-08-31,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/2012-08-31/600789_2012_z.pdf
330,2012-09-22,鲁抗医药关于与华鲁控股集团有限公司成立合资公司完成情况的公告,/disclosure/listedinfo/announcement/c/2012-09-22/600789_20120922_1.pdf
331,2012-10-08,鲁抗医药关于收购全资孙公司股权完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2012-10-08/600789_20121008_1.pdf
332,2012-10-31,鲁抗医药七届监事会第三次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2012-10-31/600789_20121031_2.pdf
333,2012-10-31,鲁抗医药七届董事会第三次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2012-10-31/600789_20121031_1.pdf
334,2012-10-31,鲁抗医药关于为子公司山东鲁抗舍里乐药业有限公司提供银行贷款担保的公告,/disclosure/listedinfo/announcement/c/2012-10-31/600789_20121031_3.pdf
335,2012-10-31,鲁抗医药第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-31/600789_2012_3.pdf
336,2012-11-24,鲁抗医药召开2012年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-11-24/600789_20121124_3.pdf
337,2012-11-24,鲁抗医药七届监事会第四次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2012-11-24/600789_20121124_1.pdf
338,2012-11-24,鲁抗医药七届董事会第四次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2012-11-24/600789_20121124_2.pdf
339,2012-12-06,鲁抗医药2012年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-12-06/600789_20121206_1.pdf
340,2012-12-14,鲁抗医药2012年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-12-14/600789_20121214_1.pdf
341,2012-12-14,鲁抗医药2012年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-12-14/600789_20121214_2.pdf
342,2013-01-19,鲁抗医药七届董事会第五次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2013-01-18/600789_20130119_1.pdf
343,2013-01-19,鲁抗医药关于山东鲁抗医药进出口公司以股权抵偿本公司债务并完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2013-01-18/600789_20130119_2.pdf
344,2013-01-26,鲁抗医药2012年度业绩预亏公告,/disclosure/listedinfo/announcement/c/2013-01-25/600789_20130126_1.pdf
345,2013-03-30,鲁抗医药关于所持山东省资产管理有限公司17%股权转让完成的公告,/disclosure/listedinfo/announcement/c/2013-03-29/600789_20130330_1.pdf
346,2013-04-02,鲁抗医药关于本公司及控股子公司获得财政扶持补贴资金的公告,/disclosure/listedinfo/announcement/c/2013-04-01/600789_20130402_1.pdf
347,2013-04-03,鲁抗医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2013-04-02/600789_20130403_1.pdf
348,2013-04-09,鲁抗医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2013-04-08/600789_20130409_1.pdf
349,2013-04-20,鲁抗医药审计报告,/disclosure/listedinfo/announcement/c/2013-04-19/600789_20130420_8.pdf
350,2013-04-20,鲁抗医药日常关联交易公告,/disclosure/listedinfo/announcement/c/2013-04-19/600789_20130420_4.pdf
351,2013-04-20,鲁抗医药七届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-19/600789_20130420_2.pdf
352,2013-04-20,鲁抗医药七届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-19/600789_20130420_5.pdf
353,2013-04-20,鲁抗医药年报摘要,/disclosure/listedinfo/announcement/c/2013-04-19/600789_2012_nzy.pdf
354,2013-04-20,鲁抗医药年报,/disclosure/listedinfo/announcement/c/2013-04-19/600789_2012_n.pdf
355,2013-04-20,鲁抗医药内部控制审计报告,/disclosure/listedinfo/announcement/c/2013-04-19/600789_20130420_7.pdf
356,2013-04-20,鲁抗医药关于召开公司2012年度股东大会通知的公告,/disclosure/listedinfo/announcement/c/2013-04-19/600789_20130420_3.pdf
357,2013-04-20,鲁抗医药独立董事关于2012年年报相关事项的独立意见,/disclosure/listedinfo/announcement/c/2013-04-19/600789_20130420_11.pdf
358,2013-04-20,鲁抗医药2012年度与关联方资金往来的专项审计报告,/disclosure/listedinfo/announcement/c/2013-04-19/600789_20130420_9.pdf
359,2013-04-20,鲁抗医药2012年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2013-04-19/600789_20130420_12.pdf
360,2013-04-20,鲁抗医药2012年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2013-04-19/600789_20130420_10.pdf
361,2013-04-25,鲁抗医药七届监事会第六次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-24/600789_20130425_3.pdf
362,2013-04-25,鲁抗医药七届董事会第七次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-24/600789_20130425_2.pdf
363,2013-04-25,鲁抗医药关于向控股子公司提供借款的公告,/disclosure/listedinfo/announcement/c/2013-04-24/600789_20130425_4.pdf
364,2013-04-25,鲁抗医药第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-24/600789_2013_1.pdf
365,2013-05-23,鲁抗医药2012年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-05-22/600789_20130523_1.pdf
366,2013-05-30,鲁抗医药2012年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-05-29/600789_20130530_1.pdf
367,2013-05-30,鲁抗医药2012年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-05-29/600789_20130530_2.pdf
368,2013-07-06,鲁抗医药关于择机开展豆油期货套期保值业务的公告,/disclosure/listedinfo/announcement/c/2013-07-05/600789_20130706_1.pdf
369,2013-07-16,鲁抗医药关于获得药品注册批件的公告,/disclosure/listedinfo/announcement/c/2013-07-15/600789_20130716_1.pdf
370,2013-08-31,鲁抗医药七届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-30/600789_20130831_3.pdf
371,2013-08-31,鲁抗医药七届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-30/600789_20130831_2.pdf
372,2013-08-31,鲁抗医药关于召开公司2013年第一次临时股东大会通知的公告,/disclosure/listedinfo/announcement/c/2013-08-30/600789_20130831_4.pdf
373,2013-08-31,鲁抗医药独立董事关于增补公司董事候选人和调整公司部分高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2013-08-30/600789_20130831_6.pdf
374,2013-08-31,鲁抗医药半年报摘要,/disclosure/listedinfo/announcement/c/2013-08-30/600789_2013_zzy.pdf
375,2013-08-31,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/2013-08-30/600789_2013_z.pdf
376,2013-09-11,鲁抗医药2013年第一次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2013-09-10/600789_20130911_1.pdf
377,2013-09-23,鲁抗医药七届董事会第十次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2013-09-22/600789_20130923_2.pdf
378,2013-09-23,鲁抗医药2013年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-09-22/600789_20130923_1.pdf
379,2013-09-23,鲁抗医药2013年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-09-22/600789_20130923_3.pdf
380,2013-10-31,鲁抗医药第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-30/600789_2013_3.pdf
381,2013-12-24,鲁抗医药关于公司2012年年度报告及其摘要中有关股东总人数的更正公告,/disclosure/listedinfo/announcement/c/2013-12-23/600789_20131224_1.pdf
382,2013-12-25,鲁抗医药关于山东鲁抗中和环保科技有限公司60%股权转让过户完成的公告,/disclosure/listedinfo/announcement/c/2013-12-24/600789_20131225_1.pdf
383,2013-12-28,鲁抗医药关于获得政府财政扶持资金的公告,/disclosure/listedinfo/announcement/c/2013-12-27/600789_20131228_1.pdf
384,2014-01-04,鲁抗医药关于对环保部通报事项整改情况的公告,/disclosure/listedinfo/announcement/c/2014-01-03/600789_20140104_1.pdf
385,2014-01-25,鲁抗医药2013年度业绩预盈公告,/disclosure/listedinfo/announcement/c/2014-01-24/600789_20140125_1.pdf
386,2014-03-28,鲁抗医药关于审计机构更名的公告,/disclosure/listedinfo/announcement/c/2014-03-27/600789_20140328_1.pdf
387,2014-04-19,鲁抗医药审计报告,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_3.pdf
388,2014-04-19,鲁抗医药日常性关联交易公告,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_14.pdf
389,2014-04-19,鲁抗医药年报摘要,/disclosure/listedinfo/announcement/c/2014-04-18/600789_2013_nzy.pdf
390,2014-04-19,鲁抗医药年报,/disclosure/listedinfo/announcement/c/2014-04-18/600789_2013_n.pdf
391,2014-04-19,鲁抗医药内部控制审计报告,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_7.pdf
392,2014-04-19,鲁抗医药关于召开2013年度股东大会的公告,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_12.pdf
393,2014-04-19,鲁抗医药关于两控股子公司合并的公告,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_18.pdf
394,2014-04-19,鲁抗医药关联交易公告,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_16.pdf
395,2014-04-19,鲁抗医药独立董事关于董事会相关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_17.pdf
396,2014-04-19,鲁抗医药独立董事关于董事会相关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_11.pdf
397,2014-04-19,鲁抗医药独立董事关于董事会相关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_15.pdf
398,2014-04-19,鲁抗医药独立董事关于董事会相关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_19.pdf
399,2014-04-19,鲁抗医药第七届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_13.pdf
400,2014-04-19,鲁抗医药第七届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_10.pdf
401,2014-04-19,鲁抗医药：关于公司2013年度与关联方资金往来的专项审计报告,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_4.pdf
402,2014-04-19,鲁抗医药2013年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_6.pdf
403,2014-04-19,鲁抗医药2013年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_5.pdf
404,2014-04-19,鲁抗医药2013年度董事会审计委员会履职报告,/disclosure/listedinfo/announcement/c/2014-04-18/600789_20140419_9.pdf
405,2014-04-30,鲁抗医药第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-29/600789_2014_1.pdf
406,2014-05-08,鲁抗医药关于召开2013年度网上业绩说明会的通知,/disclosure/listedinfo/announcement/c/2014-05-07/600789_20140508_1.pdf
407,2014-05-08,鲁抗医药关于2013年度股东大会增加网络投票方式的公告,/disclosure/listedinfo/announcement/c/2014-05-07/600789_20140508_2.pdf
408,2014-05-15,鲁抗医药2013年度股东大会会议材料,/disclosure/listedinfo/announcement/c/2014-05-14/600789_20140515_1.pdf
409,2014-05-24,鲁抗医药七届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2014-05-23/600789_20140524_3.pdf
410,2014-05-24,鲁抗医药2013年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-05-23/600789_20140524_1.pdf
411,2014-05-24,鲁抗医药2013年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-05-23/600789_20140524_2.pdf
412,2014-07-16,鲁抗医药关于公司控股子公司设立对外合资公司的公告,/disclosure/listedinfo/announcement/c/2014-07-15/600789_20140716_1.pdf
413,2014-07-19,鲁抗医药2014年上半年业绩预亏公告,/disclosure/listedinfo/announcement/c/2014-07-18/600789_20140719_1.pdf
414,2014-08-12,鲁抗医药关于两控股子公司吸收合并完成情况的公告,/disclosure/listedinfo/announcement/c/2014-08-11/600789_20140812_1.pdf
415,2014-08-30,鲁抗医药七届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-29/600789_20140830_2.pdf
416,2014-08-30,鲁抗医药七届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-29/600789_20140830_1.pdf
417,2014-08-30,鲁抗医药关于向控股子公司提供借款的公告,/disclosure/listedinfo/announcement/c/2014-08-29/600789_20140830_4.pdf
418,2014-08-30,鲁抗医药半年报摘要,/disclosure/listedinfo/announcement/c/2014-08-29/600789_2014_zzy.pdf
419,2014-08-30,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/2014-08-29/600789_2014_z.pdf
420,2014-09-24,鲁抗医药关于股东减持股份的提示性公告,/disclosure/listedinfo/announcement/c/2014-09-23/600789_20140924_1.pdf
421,2014-10-16,鲁抗医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2014-10-15/600789_20141016_1.pdf
422,2014-10-16,鲁抗医药：华鲁控股集团有限公司关于山东鲁抗医药股份有限公司股票交易异常波动的回复函,/disclosure/listedinfo/announcement/c/2014-10-15/600789_20141016_2.pdf
423,2014-10-31,鲁抗医药第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-30/600789_2014_3.pdf
424,2014-12-26,鲁抗医药关于环保问题的公告,/disclosure/listedinfo/announcement/c/2014-12-25/600789_20141226_1.pdf
425,2015-01-01,鲁抗医药2014年度业绩预亏公告,/disclosure/listedinfo/announcement/c/2014-12-31/600789_20150101_1.pdf
426,2015-01-22,鲁抗医药七届董事会第十七次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2015-01-21/600789_20150122_1.pdf
427,2015-01-22,鲁抗医药独立董事关于聘任公司总经理的独立意见,/disclosure/listedinfo/announcement/c/2015-01-21/600789_20150122_2.pdf
428,2015-01-31,鲁抗医药关于股东减持股份的公告,/disclosure/listedinfo/announcement/c/2015-01-30/600789_20150131_1.pdf
429,2015-02-03,鲁抗医药关于环保核查问题的公告,/disclosure/listedinfo/announcement/c/2015-02-02/600789_20150203_1.pdf
430,2015-02-06,鲁抗医药关于法定代表人工商变更登记完成的公告,/disclosure/listedinfo/announcement/c/2015-02-05/600789_20150206_1.pdf
431,2015-04-16,鲁抗医药年报摘要,/disclosure/listedinfo/announcement/c/2015-04-15/600789_2014_nzy.pdf
432,2015-04-16,鲁抗医药年报,/disclosure/listedinfo/announcement/c/2015-04-15/600789_2014_n.pdf
433,2015-04-16,鲁抗医药会计政策变更公告,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_12.pdf
434,2015-04-16,鲁抗医药关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_11.pdf
435,2015-04-16,鲁抗医药独立董事提名人声明,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_18.pdf
436,2015-04-16,鲁抗医药独立董事候选人声明（周建平）,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_19.pdf
437,2015-04-16,鲁抗医药独立董事候选人声明（王玉强）,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_22.pdf
438,2015-04-16,鲁抗医药独立董事候选人声明（梁仕念）,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_21.pdf
439,2015-04-16,鲁抗医药独立董事候选人声明（段继东）,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_20.pdf
440,2015-04-16,鲁抗医药独立董事关于董事会相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_17.pdf
441,2015-04-16,鲁抗医药独立董事2014年度述职报告,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_5.pdf
442,2015-04-16,鲁抗医药董事会审计委员会2014年度履职报告,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_9.pdf
443,2015-04-16,鲁抗医药董事会关于会计政策变更的说明,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_7.pdf
444,2015-04-16,鲁抗医药第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-15/600789_2015_1.pdf
445,2015-04-16,鲁抗医药第七届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_13.pdf
446,2015-04-16,鲁抗医药第七届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_23.pdf
447,2015-04-16,鲁抗医药：关于公司2014年度与关联方资金往来的专项审计报告,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_4.pdf
448,2015-04-16,鲁抗医药2015年度日常性关联交易公告,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_10.pdf
449,2015-04-16,鲁抗医药2014年度审计报告,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_3.pdf
450,2015-04-16,鲁抗医药2014年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_8.pdf
451,2015-04-16,鲁抗医药2014年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2015-04-15/600789_20150416_6.pdf
452,2015-04-21,鲁抗医药2015年度日常关联交易补充公告,/disclosure/listedinfo/announcement/c/2015-04-20/600789_20150421_1.pdf
453,2015-05-06,鲁抗医药2014年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-05-05/600789_20150506_1.pdf
454,2015-05-16,鲁抗医药独立董事关于选举董事长和聘任公司高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2015-05-15/600789_20150516_5.pdf
455,2015-05-16,鲁抗医药第八届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-05-15/600789_20150516_3.pdf
456,2015-05-16,鲁抗医药八届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-05-15/600789_20150516_2.pdf
457,2015-05-16,鲁抗医药2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-05-15/600789_20150516_1.pdf
458,2015-05-16,鲁抗医药2014年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-05-15/600789_20150516_4.pdf
459,2015-05-28,鲁抗医药关于股东减持股份的公告,/disclosure/listedinfo/announcement/c/2015-05-27/600789_20150528_1.pdf
460,2015-06-03,鲁抗医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-06-02/600789_20150603_1.pdf
461,2015-06-03,鲁抗医药：关于公司股票交易异常波动的回复函,/disclosure/listedinfo/announcement/c/2015-06-02/600789_20150603_2.pdf
462,2015-06-10,鲁抗医药关于第二大股东原股改转增股份处置实施结果的公告,/disclosure/listedinfo/announcement/c/2015-06-09/600789_20150610_1.pdf
463,2015-07-07,鲁抗医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-07-06/600789_20150707_1.pdf
464,2015-07-07,鲁抗医药：关于山东鲁抗医药股份有限公司股票交易异常波动的回复函,/disclosure/listedinfo/announcement/c/2015-07-06/600789_20150707_2.pdf
465,2015-07-11,鲁抗医药关于维护公司股价稳定的公告,/disclosure/listedinfo/announcement/c/2015-07-10/600789_20150711_1.pdf
466,2015-08-07,鲁抗医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-08-07/600789_20150807_1.pdf
467,2015-08-07,鲁抗医药：关于山东鲁抗医药股份有限公司股票交易异常波动的回复函,/disclosure/listedinfo/announcement/c/2015-08-07/600789_20150807_2.pdf
468,2015-08-29,鲁抗医药关于向控股子公司提供借款的公告,/disclosure/listedinfo/announcement/c/2015-08-29/600789_20150829_4.pdf
469,2015-08-29,鲁抗医药半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-29/600789_2015_zzy.pdf
470,2015-08-29,鲁抗医药半年报,/disclosure/listedinfo/announcement/c/2015-08-29/600789_2015_z.pdf
471,2015-08-29,鲁抗医药八届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-29/600789_20150829_3.pdf
472,2015-08-29,鲁抗医药八届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-29/600789_20150829_2.pdf
473,2015-09-30,鲁抗医药关于所持山东鲁抗立科药业有限公司40%股权转让过户完成的公告,/disclosure/listedinfo/announcement/c/2015-09-30/600789_20150930_1.pdf
474,2015-10-31,鲁抗医药第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-31/600789_2015_3.pdf
475,2015-12-03,鲁抗医药关于接受公司关联方提供财务资助的公告,/disclosure/listedinfo/announcement/c/2015-12-03/600789_20151203_1.pdf
476,2015-12-04,鲁抗医药关于撤回药品注册申请的公告,/disclosure/listedinfo/announcement/c/2015-12-04/600789_20151204_1.pdf
477,2015-12-05,鲁抗医药关于撤回药品注册申请的补充公告,/disclosure/listedinfo/announcement/c/2015-12-05/600789_20151205_1.pdf
478,2016-01-05,鲁抗医药关于撤回头孢布烯片药品注册申请的公告,/disclosure/listedinfo/announcement/c/2016-01-05/600789_20160105_1.pdf
479,2016-01-29,鲁抗医药2015年度业绩预盈公告,/disclosure/listedinfo/announcement/c/2016-01-29/600789_20160129_1.pdf
480,2016-03-09,鲁抗医药关于公司财务负责人辞职的公告,/disclosure/listedinfo/announcement/c/2016-03-09/600789_20160309_1.pdf
481,2016-03-09,鲁抗医药独立董事关于调整公司部分高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2016-03-09/600789_20160309_3.pdf
482,2016-03-09,鲁抗医药八届董事会第五次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-09/600789_20160309_2.pdf
483,2016-04-28,鲁抗医药关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-04-28/600789_20160428_7.pdf
484,2016-04-28,鲁抗医药关于续聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2016-04-28/600789_20160428_5.pdf
485,2016-04-28,鲁抗医药关于投资建设“鲁抗生物医药循环经济产业园”的公告,/disclosure/listedinfo/announcement/c/2016-04-28/600789_20160428_6.pdf
486,2016-04-28,鲁抗医药独立董事关于董事会相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-04-28/600789_20160428_16.pdf
487,2016-04-28,鲁抗医药独立董事对公司2016年日常关联交易的事前认可声明,/disclosure/listedinfo/announcement/c/2016-04-28/600789_20160428_17.pdf
488,2016-04-28,鲁抗医药董事会审计委员会2015年度履职报告,/disclosure/listedinfo/announcement/c/2016-04-28/600789_20160428_15.pdf
489,2016-04-28,鲁抗医药第八届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-28/600789_20160428_3.pdf
490,2016-04-28,鲁抗医药第八届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-28/600789_20160428_2.pdf
491,2016-04-28,鲁抗医药：审计报告,/disclosure/listedinfo/announcement/c/2016-04-28/600789_20160428_10.pdf
492,2016-04-28,鲁抗医药：内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-04-28/600789_20160428_14.pdf
493,2016-04-28,鲁抗医药：关于山东鲁抗医药股份有限公司2015年度与关联方资金往来的专项审计报告,/disclosure/listedinfo/announcement/c/2016-04-28/600789_20160428_11.pdf
494,2016-04-28,鲁抗医药2016年度日常关联交易公告,/disclosure/listedinfo/announcement/c/2016-04-28/600789_20160428_4.pdf
495,2016-04-28,鲁抗医药2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-28/600789_2016_1.pdf
496,2016-04-28,鲁抗医药2015年年度报告摘要,/disclosure/listedinfo/announcement/c/2016-04-28/600789_2015_nzy.pdf
497,2016-04-28,鲁抗医药2015年年度报告,/disclosure/listedinfo/announcement/c/2016-04-28/600789_2015_n.pdf
498,2016-04-28,鲁抗医药2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-04-28/600789_20160428_13.pdf
499,2016-04-28,鲁抗医药2015年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2016-04-28/600789_20160428_12.pdf
500,2016-05-17,鲁抗医药关于转让控股子公司股权及债权的公告,/disclosure/listedinfo/announcement/c/2016-05-17/600789_20160517_2.pdf
501,2016-05-17,鲁抗医药2015年年度股东大会会议材料,/disclosure/listedinfo/announcement/c/2016-05-17/600789_20160517_1.pdf
502,2016-05-18,鲁抗医药拟转让菏泽鲁抗舍里乐药业有限公司股权项目所涉及的菏泽鲁抗舍里乐药业有限公司股东全部权益评估报告,/disclosure/listedinfo/announcement/c/2016-05-18/600789_20160518_4.pdf
503,2016-05-18,鲁抗医药关于转让控股子公司股权及债权的补充公告,/disclosure/listedinfo/announcement/c/2016-05-18/600789_20160518_1.pdf
504,2016-05-18,鲁抗医药独立董事关于转让控股子公司股权及债权的独立意见,/disclosure/listedinfo/announcement/c/2016-05-18/600789_20160518_2.pdf
505,2016-05-18,鲁抗医药：菏泽鲁抗舍里乐药业有限公司审计报告,/disclosure/listedinfo/announcement/c/2016-05-18/600789_20160518_3.pdf
506,2016-05-24,鲁抗医药关于所属锅炉二氧化硫超标问题的公告,/disclosure/listedinfo/announcement/c/2016-05-24/600789_20160524_1.pdf
507,2016-05-27,鲁抗医药关于收到上海证券交易所2015年年度报告事后审核问询函的公告,/disclosure/listedinfo/announcement/c/2016-05-27/600789_20160527_2.pdf
508,2016-05-27,鲁抗医药2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-05-27/600789_20160527_1.pdf
509,2016-05-27,鲁抗医药2015年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-05-27/600789_20160527_3.pdf
510,2016-06-02,鲁抗医药关于上海证券交易所2015年年度报告事后审核问询函的回复公告,/disclosure/listedinfo/announcement/c/2016-06-02/600789_20160602_1.pdf
511,2016-06-02,鲁抗医药：关于对山东鲁抗医药股份有限公司2015年年度报告的事后审核问询函中有关问题的回复,/disclosure/listedinfo/announcement/c/2016-06-02/600789_20160602_2.pdf
512,2016-06-25,鲁抗医药关于全资子公司获得《兽药GMP证书》的公告,/disclosure/listedinfo/announcement/c/2016-06-25/600789_20160625_1.pdf
513,2016-07-14,鲁抗医药关于持股5%以上股东减持股份的提示性公告,/disclosure/listedinfo/announcement/c/2016-07-14/600789_20160714_1.pdf
514,2016-07-16,鲁抗医药简式权益变动报告书,/disclosure/listedinfo/announcement/c/2016-07-16/600789_20160716_3.pdf
515,2016-07-16,鲁抗医药关于股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2016-07-16/600789_20160716_2.pdf
516,2016-07-16,鲁抗医药关于持股5%以上股东减持股份的提示性公告,/disclosure/listedinfo/announcement/c/2016-07-16/600789_20160716_1.pdf
517,2016-07-23,鲁抗医药简式权益变动报告书,/disclosure/listedinfo/announcement/c/2016-07-23/600789_20160723_2.pdf
518,2016-07-23,鲁抗医药关于持股5%以上股东减持至5%以下的提示性公告,/disclosure/listedinfo/announcement/c/2016-07-23/600789_20160723_1.pdf
519,2016-08-27,鲁抗医药信息披露暂缓与豁免业务内部管理制度,/disclosure/listedinfo/announcement/c/2016-08-27/600789_20160827_7.pdf
520,2016-08-27,鲁抗医药关于向控股子公司提供借款的公告,/disclosure/listedinfo/announcement/c/2016-08-27/600789_20160827_4.pdf
521,2016-08-27,鲁抗医药关于公司2016年半年度主要经营数据的公告,/disclosure/listedinfo/announcement/c/2016-08-27/600789_20160827_5.pdf
522,2016-08-27,鲁抗医药八届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-27/600789_20160827_3.pdf
523,2016-08-27,鲁抗医药八届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-27/600789_20160827_2.pdf
524,2016-08-27,鲁抗医药2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-27/600789_2016_zzy.pdf
525,2016-08-27,鲁抗医药2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-27/600789_2016_z.pdf
526,2016-09-02,鲁抗医药关于向控股子公司提供借款的关联交易公告,/disclosure/listedinfo/announcement/c/2016-09-02/600789_20160902_1.pdf
527,2016-09-02,鲁抗医药独立董事关于关联交易事项的事前认可声明,/disclosure/listedinfo/announcement/c/2016-09-02/600789_20160902_2.pdf
528,2016-09-02,鲁抗医药独立董事关于关联交易发表的独立意见,/disclosure/listedinfo/announcement/c/2016-09-02/600789_20160902_3.pdf
529,2016-09-08,鲁抗医药关于控股子公司股权及债权转让完成的公告,/disclosure/listedinfo/announcement/c/2016-09-08/600789_20160908_1.pdf
530,2016-09-09,鲁抗医药关于控股子公司股权及债权转让完成情况的补充公告,/disclosure/listedinfo/announcement/c/2016-09-09/600789_20160909_1.pdf
531,2016-10-29,鲁抗医药2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-29/600789_2016_3.pdf
532,2016-11-17,鲁抗医药关于策划非公开发行股票事项的停牌公告,/disclosure/listedinfo/announcement/c/2016-11-17/600789_20161117_1.pdf
533,2016-11-24,鲁抗医药关于筹划非公开发行股票事项停牌的进展公告,/disclosure/listedinfo/announcement/c/2016-11-24/600789_20161124_1.pdf
534,2016-11-30,鲁抗医药未来三年（2016年-2018年）股东回报规划,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_10.pdf
535,2016-11-30,鲁抗医药募集资金使用管理办法（2016年11月修订）,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_11.pdf
536,2016-11-30,鲁抗医药关于与特定对象签订附条件生效的股份认购合同公告,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_5.pdf
537,2016-11-30,鲁抗医药关于修改《公司章程》的公告,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_9.pdf
538,2016-11-30,鲁抗医药关于非公开发行股票涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_4.pdf
539,2016-11-30,鲁抗医药关于非公开发行A股股票摊薄即期回报风险提示及采取填补措施的公告,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_6.pdf
540,2016-11-30,鲁抗医药关于筹划非公开发行股票事项的复牌公告,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_1.pdf
541,2016-11-30,鲁抗医药关于2016年度非公开发行A股股票无需编制前次募集资金使用情况报告的说明,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_15.pdf
542,2016-11-30,鲁抗医药公司章程（2016修订）,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_16.pdf
543,2016-11-30,鲁抗医药非公开发行股票募集资金投资项目的可行性分析报告,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_14.pdf
544,2016-11-30,鲁抗医药非公开发行A股股票预案,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_8.pdf
545,2016-11-30,鲁抗医药独立董事关于公司非公开发行股票涉及关联交易事项的事前认可意见,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_12.pdf
546,2016-11-30,鲁抗医药独立董事关于公司第八届董事会第十一次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_13.pdf
547,2016-11-30,鲁抗医药董事、高级管理人员关于非公开发行股票摊薄即期回报采取填补措施承诺的公告,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_7.pdf
548,2016-11-30,鲁抗医药第八届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_3.pdf
549,2016-11-30,鲁抗医药第八届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-11-30/600789_20161130_2.pdf
550,2016-12-13,鲁抗医药关于接受公司关联方提供财务资助的公告,/disclosure/listedinfo/announcement/c/2016-12-13/600789_20161213_1.pdf
551,2016-12-13,鲁抗医药独立董事关于接受公司关联方提供财务资助事项的事前认可声明,/disclosure/listedinfo/announcement/c/2016-12-13/600789_20161213_2.pdf
552,2016-12-13,鲁抗医药独立董事关于接受公司关联方提供财务资助事项的独立意见,/disclosure/listedinfo/announcement/c/2016-12-13/600789_20161213_3.pdf
553,2016-12-21,鲁抗医药关于非公开发行股票募投项目相关事项的说明公告,/disclosure/listedinfo/announcement/c/2016-12-21/600789_20161221_1.pdf
554,2016-12-24,鲁抗医药关于召开2017年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-12-24/600789_20161224_2.pdf
555,2016-12-24,鲁抗医药关于非公开发行A股预案获得山东省国资委核准的公告,/disclosure/listedinfo/announcement/c/2016-12-24/600789_20161224_1.pdf
556,2016-12-30,鲁抗医药关于子公司获得新兽药注册证书的公告,/disclosure/listedinfo/announcement/c/2016-12-30/600789_20161230_1.pdf
557,2016-12-30,鲁抗医药2017年第一次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2016-12-30/600789_20161230_2.pdf
558,2017-01-10,鲁抗医药2017年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-01-10/600789_20170110_1.pdf
559,2017-01-10,鲁抗医药2017年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2017-01-10/600789_20170110_2.pdf
560,2017-01-24,鲁抗医药2016年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2017-01-24/600789_20170124_1.pdf
561,2017-01-26,鲁抗医药关于非公开发行股票申请获中国证监会受理的公告,/disclosure/listedinfo/announcement/c/2017-01-26/600789_20170126_1.pdf
562,2017-03-23,鲁抗医药关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-03-23/600789_20170323_3.pdf
563,2017-03-23,鲁抗医药关于续聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2017-03-23/600789_20170323_1.pdf
564,2017-03-23,鲁抗医药关于2017年度固定资产投资计划的公告,/disclosure/listedinfo/announcement/c/2017-03-23/600789_20170323_2.pdf
565,2017-03-23,鲁抗医药独立董事关于董事会相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-03-23/600789_20170323_16.pdf
566,2017-03-23,鲁抗医药独立董事对公司2017年日常关联交易的事前认可声明,/disclosure/listedinfo/announcement/c/2017-03-23/600789_20170323_15.pdf
567,2017-03-23,鲁抗医药董事会审计委员会2016年度履职报告,/disclosure/listedinfo/announcement/c/2017-03-23/600789_20170323_14.pdf
568,2017-03-23,鲁抗医药第八届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-23/600789_20170323_6.pdf
569,2017-03-23,鲁抗医药第八届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-23/600789_20170323_5.pdf
570,2017-03-23,鲁抗医药：审计报告,/disclosure/listedinfo/announcement/c/2017-03-23/600789_20170323_9.pdf
571,2017-03-23,鲁抗医药：内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-03-23/600789_20170323_13.pdf
572,2017-03-23,鲁抗医药：非经营性资金占用及其他关联资金往来情况的专项说明,/disclosure/listedinfo/announcement/c/2017-03-23/600789_20170323_10.pdf
573,2017-03-23,鲁抗医药2017年度日常关联交易公告,/disclosure/listedinfo/announcement/c/2017-03-23/600789_20170323_7.pdf
574,2017-03-23,鲁抗医药2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-03-23/600789_2016_nzy.pdf
575,2017-03-23,鲁抗医药2016年年度报告,/disclosure/listedinfo/announcement/c/2017-03-23/600789_2016_n.pdf
576,2017-03-23,鲁抗医药2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-03-23/600789_20170323_12.pdf
577,2017-03-23,鲁抗医药2016年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2017-03-23/600789_20170323_11.pdf
578,2017-03-25,鲁抗医药独立董事关于公司对外担保情况的专项说明,/disclosure/listedinfo/announcement/c/2017-03-25/600789_20170325_1.pdf
579,2017-03-28,鲁抗医药关于收到《中国证监会行政许可项目审查反馈意见通知书》的公告,/disclosure/listedinfo/announcement/c/2017-03-28/600789_20170328_1.pdf
580,2017-04-15,鲁抗医药2016年年度股东大会会议材料,/disclosure/listedinfo/announcement/c/2017-04-15/600789_20170415_1.pdf
581,2017-04-20,鲁抗医药与海通证券股份有限公司关于山东鲁抗医药股份有限公司非公开发行股票申请文件反馈意见的回复,/disclosure/listedinfo/announcement/c/2017-04-20/600789_20170420_2.pdf
582,2017-04-20,鲁抗医药关于非公开发行股票申请文件反馈意见回复的公告,/disclosure/listedinfo/announcement/c/2017-04-20/600789_20170420_1.pdf
583,2017-04-20,鲁抗医药：上会会计师事务所（特殊普通合伙）关于山东鲁抗医药股份有限公司非公开发行股票申请文件反馈意见中有关问题的核查意见,/disclosure/listedinfo/announcement/c/2017-04-20/600789_20170420_4.pdf
584,2017-04-20,鲁抗医药：华鲁控股集团有限公司关于未来六个月不减持受托管理的公司股票的承诺,/disclosure/listedinfo/announcement/c/2017-04-20/600789_20170420_3.pdf
585,2017-04-20,鲁抗医药：北京市通商律师事务所关于山东鲁抗医药股份有限公司非公开发行A股股票之补充法律意见书（二）,/disclosure/listedinfo/announcement/c/2017-04-20/600789_20170420_5.pdf
586,2017-04-27,鲁抗医药2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-27/600789_2017_1.pdf
587,2017-04-27,鲁抗医药2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-04-27/600789_20170427_2.pdf
588,2017-04-27,鲁抗医药2016年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-04-27/600789_20170427_4.pdf
589,2017-06-15,鲁抗医药2016年年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-06-15/600789_20170615_1.pdf
590,2017-07-04,鲁抗医药关于召开2017年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-07-04/600789_20170704_6.pdf
591,2017-07-04,鲁抗医药关于拟向关联方借款的关联交易公告,/disclosure/listedinfo/announcement/c/2017-07-04/600789_20170704_2.pdf
592,2017-07-04,鲁抗医药独立董事关于拟向关联方借款事项的事前认可声明,/disclosure/listedinfo/announcement/c/2017-07-04/600789_20170704_3.pdf
593,2017-07-04,鲁抗医药独立董事关于拟向关联方借款事项的独立意见,/disclosure/listedinfo/announcement/c/2017-07-04/600789_20170704_4.pdf
594,2017-07-04,鲁抗医药八届董事会审计委员会关于拟向关联方借款事项的审核意见,/disclosure/listedinfo/announcement/c/2017-07-04/600789_20170704_5.pdf
595,2017-07-04,鲁抗医药八届董事会第十五次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2017-07-04/600789_20170704_1.pdf
596,2017-07-13,鲁抗医药2017年第二次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2017-07-13/600789_20170713_1.pdf
597,2017-07-21,鲁抗医药2017年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-07-21/600789_20170721_1.pdf
598,2017-07-21,鲁抗医药2017年第二次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2017-07-21/600789_20170721_2.pdf
599,2017-08-17,鲁抗医药关于实施2016年度利润分配方案后调整非公开发行股票发行底价和发行数量的公告,/disclosure/listedinfo/announcement/c/2017-08-17/600789_20170817_1.pdf
600,2017-08-26,鲁抗医药关于修改《公司章程》的公告,/disclosure/listedinfo/announcement/c/2017-08-26/600789_20170826_5.pdf
601,2017-08-26,鲁抗医药关于新增固定资产投资项目的公告,/disclosure/listedinfo/announcement/c/2017-08-26/600789_20170826_7.pdf
602,2017-08-26,鲁抗医药公司章程（修订稿）,/disclosure/listedinfo/announcement/c/2017-08-26/600789_20170826_6.pdf
603,2017-08-26,鲁抗医药八届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-26/600789_20170826_4.pdf
604,2017-08-26,鲁抗医药八届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-26/600789_20170826_3.pdf
605,2017-08-26,鲁抗医药2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-26/600789_2017_zzy.pdf
606,2017-08-26,鲁抗医药2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-26/600789_2017_z.pdf
607,2017-08-30,鲁抗医药关于非公开发行A股股票申请获得中国证监会发行审核委员会审核通过的公告,/disclosure/listedinfo/announcement/c/2017-08-30/600789_20170830_1.pdf
608,2017-09-02,鲁抗医药关于公司获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2017-09-02/600789_20170902_2.pdf
609,2017-09-02,鲁抗医药关于独立董事辞职的公告,/disclosure/listedinfo/announcement/c/2017-09-02/600789_20170902_1.pdf
610,2017-09-14,鲁抗医药关于召开2017年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-09-14/600789_20170914_5.pdf
611,2017-09-14,鲁抗医药独立董事提名人声明,/disclosure/listedinfo/announcement/c/2017-09-14/600789_20170914_4.pdf
612,2017-09-14,鲁抗医药独立董事候选人声明,/disclosure/listedinfo/announcement/c/2017-09-14/600789_20170914_3.pdf
613,2017-09-14,鲁抗医药独立董事关于选举公司独立董事的独立意见,/disclosure/listedinfo/announcement/c/2017-09-14/600789_20170914_2.pdf
614,2017-09-14,鲁抗医药八届董事会第十七次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2017-09-14/600789_20170914_1.pdf
615,2017-09-21,鲁抗医药2017年第三次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2017-09-21/600789_20170921_1.pdf
616,2017-09-30,鲁抗医药2017年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-09-30/600789_20170930_1.pdf
617,2017-09-30,鲁抗医药2017年第三次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2017-09-30/600789_20170930_2.pdf
618,2017-10-28,鲁抗医药关于对外投资设立合资公司的公告,/disclosure/listedinfo/announcement/c/2017-10-28/600789_20171028_5.pdf
619,2017-10-28,鲁抗医药独立董事关于对外投资设立合资公司的独立意见,/disclosure/listedinfo/announcement/c/2017-10-28/600789_20171028_6.pdf
620,2017-10-28,鲁抗医药八届监事会第十一次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-28/600789_20171028_4.pdf
621,2017-10-28,鲁抗医药八届董事会第十八次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-28/600789_20171028_3.pdf
622,2017-10-28,鲁抗医药2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-28/600789_2017_3.pdf
623,2017-11-14,鲁抗医药关于非公开发行股票获得中国证监会核准批文的公告,/disclosure/listedinfo/announcement/c/2017-11-14/600789_20171114_1.pdf
624,2017-12-22,鲁抗医药关于召开2018年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-12-22/600789_20171222_5.pdf
625,2017-12-22,鲁抗医药关于延长非公开发行股票股东大会决议及授权有效期的公告,/disclosure/listedinfo/announcement/c/2017-12-22/600789_20171222_4.pdf
626,2017-12-22,鲁抗医药独立董事关于延长非公开发行股票决议有效期及股东会对董事会授权有效期的独立意见,/disclosure/listedinfo/announcement/c/2017-12-22/600789_20171222_2.pdf
627,2017-12-22,鲁抗医药八届监事会第十二次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-22/600789_20171222_3.pdf
628,2017-12-22,鲁抗医药八届董事会第十九次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-22/600789_20171222_1.pdf
629,2017-12-29,鲁抗医药2018年第一次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2017-12-29/600789_20171229_1.pdf
630,2017-12-30,鲁抗医药关于公司及下属子公司收到政府补助的公告,/disclosure/listedinfo/announcement/c/2017-12-30/600789_20171230_2.pdf
631,2017-12-30,鲁抗医药关于对外投资进展暨合资公司完成注册登记的公告,/disclosure/listedinfo/announcement/c/2017-12-30/600789_20171230_1.pdf
632,2018-01-09,鲁抗医药关于执行新会计准则的公告,/disclosure/listedinfo/announcement/c/2018-01-09/600789_20180109_4.pdf
633,2018-01-09,鲁抗医药独立董事关于第八届董事会第二十次（临时）会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2018-01-09/600789_20180109_2.pdf
634,2018-01-09,鲁抗医药八届监事会第十三次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2018-01-09/600789_20180109_3.pdf
635,2018-01-09,鲁抗医药八届董事会第二十次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2018-01-09/600789_20180109_1.pdf
636,2018-01-09,鲁抗医药2018年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2018-01-09/600789_20180109_5.pdf
637,2018-01-09,鲁抗医药2018年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2018-01-09/600789_20180109_6.pdf
638,2018-01-26,鲁抗医药关于公司获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2018-01-26/600789_20180126_1.pdf
639,2018-01-26,鲁抗医药2017年度业绩预增公告,/disclosure/listedinfo/announcement/c/2018-01-26/600789_20180126_2.pdf
640,2018-02-09,鲁抗医药关于媒体报道的澄清说明公告,/disclosure/listedinfo/announcement/c/2018-02-09/600789_20180209_1.pdf
641,2018-02-10,鲁抗医药关于投资者调研情况的公告,/disclosure/listedinfo/announcement/c/2018-02-10/600789_20180210_1.pdf
